Roberto Borea

637 total citations
25 papers, 363 citations indexed

About

Roberto Borea is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Roberto Borea has authored 25 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Roberto Borea's work include Cancer Genomics and Diagnostics (4 papers), BRCA gene mutations in cancer (3 papers) and CAR-T cell therapy research (3 papers). Roberto Borea is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), BRCA gene mutations in cancer (3 papers) and CAR-T cell therapy research (3 papers). Roberto Borea collaborates with scholars based in Italy, United States and Belgium. Roberto Borea's co-authors include Christian Rolfo, Peter A. van Dam, David S. Hong, Shahanavaj Khan, Rafael Sirera, Rut Porta, Aung Naing, Tindara Franchina, Nele Van Der Steen and Pablo Reclusa and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and International Journal of Molecular Sciences.

In The Last Decade

Roberto Borea

22 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Borea Italy 7 186 169 82 77 47 25 363
Marta Cañamero Spain 10 164 0.9× 179 1.1× 56 0.7× 86 1.1× 70 1.5× 21 410
Longwen Xu China 10 172 0.9× 185 1.1× 61 0.7× 81 1.1× 94 2.0× 24 361
Esther Redín Spain 12 128 0.7× 175 1.0× 70 0.9× 72 0.9× 111 2.4× 19 337
Gesa Schuebbe Germany 3 239 1.3× 147 0.9× 95 1.2× 163 2.1× 54 1.1× 6 445
Bryan Wong United States 11 153 0.8× 201 1.2× 113 1.4× 60 0.8× 77 1.6× 20 431
Katrin Almstedt Germany 12 270 1.5× 125 0.7× 95 1.2× 95 1.2× 119 2.5× 33 403
Shereen Rafee Ireland 8 148 0.8× 161 1.0× 76 0.9× 38 0.5× 41 0.9× 15 328
Rebecca Pharaon United States 10 210 1.1× 181 1.1× 166 2.0× 65 0.8× 82 1.7× 27 408
Jii Bum Lee South Korea 12 322 1.7× 187 1.1× 140 1.7× 171 2.2× 61 1.3× 47 545
Songwei Feng China 11 84 0.5× 130 0.8× 75 0.9× 61 0.8× 69 1.5× 21 266

Countries citing papers authored by Roberto Borea

Since Specialization
Citations

This map shows the geographic impact of Roberto Borea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Borea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Borea more than expected).

Fields of papers citing papers by Roberto Borea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Borea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Borea. The network helps show where Roberto Borea may publish in the future.

Co-authorship network of co-authors of Roberto Borea

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Borea. A scholar is included among the top collaborators of Roberto Borea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Borea. Roberto Borea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2025). Prognostic implications of risk definitions from the monarchE and NATALEE trials. JNCI Journal of the National Cancer Institute. 117(6). 1198–1208. 3 indexed citations
2.
Melo, Andréia Cristina de, Roberto Borea, Marcelo Corassa, et al.. (2025). Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022. Cancer Research Communications. 5(12). 2236–2248.
3.
Borea, Roberto, Eleonora Nicolò, Diego de Miguel‐Pérez, et al.. (2025). Cancer in a drop: Advances in liquid biopsy in 2024. Critical Reviews in Oncology/Hematology. 213. 104776–104776. 6 indexed citations
4.
Roscigno, Giuseppina, Roberto Borea, Gianluca Russo, et al.. (2025). The potential application of stroma modulation in targeting tumor cells: Focus on pancreatic cancer and breast cancer models. Seminars in Cancer Biology. 113. 151–175. 2 indexed citations
5.
Borea, Roberto & Carolina Reduzzi. (2025). The growing field of liquid biopsy and its Snowball effect on reshaping cancer management. PubMed. 8. 100293–100293. 3 indexed citations
6.
Borea, Roberto, et al.. (2025). Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations. Journal for ImmunoTherapy of Cancer. 13(8). e012288–e012288. 2 indexed citations
7.
Borea, Roberto, Susana García‐Recio, Siobhán O’Connor, et al.. (2025). B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 13(5). e011533–e011533. 4 indexed citations
8.
Arecco, Luca, Roberto Borea, Stefano Spinaci, et al.. (2024). Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert Review of Anticancer Therapy. 24(9). 803–817. 2 indexed citations
9.
Borea, Roberto, Bárbara Cardinali, Luca Arecco, et al.. (2024). 83P Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in eary high risk breast cancer: The CITUCEL trial update. Annals of Oncology. 35. S247–S247. 1 indexed citations
10.
Molinelli, Chiara, Flavia Jacobs, Guilherme Nader Marta, et al.. (2024). Ovarian Suppression: Early Menopause and Late Effects. Current Treatment Options in Oncology. 25(4). 523–542. 5 indexed citations
11.
Battistuzzi, Linda, Eva Blondeaux, Francesca Poggio, et al.. (2024). Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer. BMC Palliative Care. 23(1). 129–129.
12.
Blondeaux, Eva, Luca Arecco, Paola Scaruffi, et al.. (2023). The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition. Cancers. 15(20). 4923–4923. 14 indexed citations
13.
Poggio, Francesca, Simone Nardin, Marta Perachino, et al.. (2023). Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?. Expert Opinion on Pharmacotherapy. 24(18). 1975–1984. 1 indexed citations
14.
Borea, Roberto, Gabriella Cirmena, Lorenzo Ferrando, et al.. (2022). Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study. Journal of Translational Medicine. 20(1). 230–230.
15.
Dalmasso, Bruna, Alberto Puccini, Fabio Catalano, et al.. (2022). Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. International Journal of Molecular Sciences. 23(9). 4709–4709. 15 indexed citations
16.
Tagliamento, Marco, Elisa Agostinetto, Roberto Borea, et al.. (2021). VISTA: A Promising Target for Cancer Immunotherapy?. SHILAP Revista de lepidopterología. Volume 10. 185–200. 41 indexed citations
17.
Rebuzzi, Sara Elena, Giuseppe Luigi Banna, Luigi Cerbone, et al.. (2021). Durable Response after Immunotherapy Discontinuation for Delayed and Severe Immune-related Adverse Event: A Case Report. Immunotherapy. 13(17). 1379–1386. 2 indexed citations
18.
Borea, Roberto, Sara Elena Rebuzzi, Giuseppe Luigi Banna, et al.. (2021). Immunotherapy Retreatment: Case Report, Review of the Literature and Proposal for the Definition of Different Scenarios. Immunotherapy. 13(8). 645–652. 4 indexed citations
19.
20.
Porta, Rut, Roberto Borea, Shahanavaj Khan, et al.. (2017). FGFR a promising druggable target in cancer: Molecular biology and new drugs. Critical Reviews in Oncology/Hematology. 113. 256–267. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Cañamero Breakdown of academic impact, for papers by Longwen Xu Breakdown of academic impact, for papers by Esther Redín Breakdown of academic impact, for papers by Gesa Schuebbe Breakdown of academic impact, for papers by Bryan Wong Breakdown of academic impact, for papers by Katrin Almstedt Breakdown of academic impact, for papers by Shereen Rafee Breakdown of academic impact, for papers by Rebecca Pharaon Breakdown of academic impact, for papers by Jii Bum Lee Breakdown of academic impact, for papers by Songwei Feng
Rankless by CCL
2026